Objectives: ANCA-associated vasculitis (AAV) are a set of rare, chronic conditions, which have an increased health burden compared with the general population. The objective was to quantify this burden for Scottish patients with AAV by exploring healthcare utilisation in a well-defined cohort. Methods: NHS Scotland provided longitudinal, historic multicentre data on routinely collected health records from seven centres across Scotland, UK. Included were 543 patients with AAV and up to five matches per patient from the general population (n=2671). Included healthcare utilisation parameters were inpatient hospitalisation, outpatient encounters, accidents and emergencies and associated costs. Poisson and linear regression models were conducted...
Background: There is a need for interoperable national registries to enable reporting of real-world ...
Objective: Antineutrophil cytoplasmic antibody–associated vasculitis (AAV) is considered a chronic, ...
OBJECTIVE Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is considered a chronic...
Aim: The primary aim of the study was to obtain the prevalence of ANCA-associated vasculitis (AAV) i...
Background/Objectives: Care models employed to manage systemic vasculitis typically vary between reg...
Background/ Objectives: People with ANCA-associated vasculitis (AAV) have high rates of hospital adm...
Introduction: Rare diseases have gained recognition over the past decade as an important area for h...
Background/ Objectives: The Vasculitis Outcomes In relation to Care Experience Study (VOICES), aims ...
Background: We examined the demographic characteristics, treatment and outcomes of ANCA-associated v...
The global burden of anti-neutrophil cytoplasmic antibody vasculitis is high but currently unquantif...
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare multis...
Background: The ANCA –associated vasculitides (AAVs) are a group of rare, potentially life-threateni...
© 2018 Article author(s). Objectives To finalise and validate a disease-specific patient-reported ou...
Objective The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisys...
Objective: Despite the high incidence of ANCA-associated vasculitis (AAV) in elderly patients, clini...
Background: There is a need for interoperable national registries to enable reporting of real-world ...
Objective: Antineutrophil cytoplasmic antibody–associated vasculitis (AAV) is considered a chronic, ...
OBJECTIVE Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is considered a chronic...
Aim: The primary aim of the study was to obtain the prevalence of ANCA-associated vasculitis (AAV) i...
Background/Objectives: Care models employed to manage systemic vasculitis typically vary between reg...
Background/ Objectives: People with ANCA-associated vasculitis (AAV) have high rates of hospital adm...
Introduction: Rare diseases have gained recognition over the past decade as an important area for h...
Background/ Objectives: The Vasculitis Outcomes In relation to Care Experience Study (VOICES), aims ...
Background: We examined the demographic characteristics, treatment and outcomes of ANCA-associated v...
The global burden of anti-neutrophil cytoplasmic antibody vasculitis is high but currently unquantif...
Background: Antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is a rare multis...
Background: The ANCA –associated vasculitides (AAVs) are a group of rare, potentially life-threateni...
© 2018 Article author(s). Objectives To finalise and validate a disease-specific patient-reported ou...
Objective The antineutrophil cytoplasmic antibody (ANCA)-associated vasculitides (AAVs) are multisys...
Objective: Despite the high incidence of ANCA-associated vasculitis (AAV) in elderly patients, clini...
Background: There is a need for interoperable national registries to enable reporting of real-world ...
Objective: Antineutrophil cytoplasmic antibody–associated vasculitis (AAV) is considered a chronic, ...
OBJECTIVE Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) is considered a chronic...